2013, Volume 6, Issue 4, pp 403 – 408
Brehar AC *
Brehar FM ** ***
Bulgar AC *
Dumitrache C * ***
* “C.I. Parhon” National Institute of Endocrinology, Bucharest
** “Bagdasar Arseni” Emergency Hospital, Bucharest
*** ”Carol Davila” University of Medicine and Pharmacy, Bucharest
Correspondence to:Brehar Andreea Cristiana, MD 34-38 Aviatorilor Avenue, District 1, Bucharest, P.O. 011863 Fax: (+4 021) 317 06 07; Mobile phone: 0761668328; E-mail: abrehar@yahoo.de
Abstract
Differentiated thyroid carcinoma (DTC) has a favorable prognosis, but it is important to identify those patients who have a high risk of progressive disease and DTC-related death at the time of diagnosis. Analyzing genetic and epigenetic alterations in thyroid cancer may play a role in tumor diagnosis, prognostic and therapeutic strategies.
PMC ID: 4034295
PubMed ID: 24868250
DOI:
Article Publishing Date (print): 15-12-2013
Available Online: 25-12-2013
ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life
Copyright License: Open Access
This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/
